Prostatic Neoplasms  >>  Torisel (temsirolimus)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Torisel (temsirolimus) / Pfizer
NCT00512668: Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer

Terminated
1
24
US
leuprolide acetate, Enantone, LEUP, Lupron, Lupron Depot, goserelin acetate, ICI-118630, ZDX, Zoladex, bicalutamide, Casodex, CDX, nilutamide, ANAN, Anandron, Nilandron, flutamide, Eulexin, Eulexine, FLUT, Sch 13521, temsirolimus, CCI-779, cell cycle inhibitor 779, Torisel, laboratory biomarker analysis
National Cancer Institute (NCI)
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer
01/08
 
NCT01155258: Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Completed
1
19
US
temsirolimus, CCI-779, cell cycle inhibitor 779, rapamycin analog CCI-779, Torisel, vinorelbine ditartrate, Biovelbin, Eunades, navelbine ditartrate, NVB, vinorelbine tartrate, VNB
University of Southern California, Wyeth is now a wholly owned subsidiary of Pfizer
Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma, Male Breast Cancer, Malignant Paraganglioma, Metastatic Gastrointestinal Carcinoid Tumor, Metastatic Pheochromocytoma, Pancreatic Polypeptide Tumor, Recurrent Breast Cancer, Recurrent Cervical Cancer, Recurrent Endometrial Carcinoma, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Islet Cell Carcinoma, Recurrent Neuroendocrine Carcinoma of the Skin, Recurrent Non-small Cell Lung Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Recurrent Pheochromocytoma, Recurrent Prostate Cancer, Recurrent Renal Cell Cancer, Recurrent Small Cell Lung Cancer, Recurrent Uterine Sarcoma, Regional Gastrointestinal Carcinoid Tumor, Regional Pheochromocytoma, Stage III Cervical Cancer, Stage III Endometrial Carcinoma, Stage III Neuroendocrine Carcinoma of the Skin, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor, Stage III Prostate Cancer, Stage III Renal Cell Cancer, Stage III Uterine Sarcoma, Stage IIIA Breast Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Breast Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer, Stage IV Endometrial Carcinoma, Stage IV Neuroendocrine Carcinoma of the Skin, Stage IV Non-small Cell Lung Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor, Stage IV Prostate Cancer, Stage IV Renal Cell Cancer, Stage IV Uterine Sarcoma, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer, Thyroid Gland Medullary Carcinoma
01/13
05/14
NCT01183663: Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Checkmark Lenalidomide in combination with temsirolimus in pts with adv cancer
Aug 2013 - Aug 2013: Lenalidomide in combination with temsirolimus in pts with adv cancer
Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Checkmark Data-AACR
More
Completed
1
180
US
Lenalidomide, CC-5013, Revlimid, Bevacizumab, Avastin, Anti-VEGF monoclonal antibody, rhuMAB-VEGF, Sorafenib, Nexavar, BAY 43-90006, Temsirolimus, CC-779, Torisel, Oxaliplatin, Eloxatin, Leucovorin, Citrovorum, Wellcovorin, 5-fluorouracil, 5-FU, Adrucil, Efudex
M.D. Anderson Cancer Center, Celgene
Advanced Cancers
05/16
05/16

Download Options